MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to Fine-Tune treatment for blinding eye disease
Disease control Not yet recruitingThis study tests a drug called faricimab (Vabysmo) in 64 adults with wet age-related macular degeneration, a leading cause of vision loss. Participants receive eye injections every 4 weeks for 4 doses, then the schedule is adjusted based on how the eye responds. The goal is to co…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE4 • Sponsor: Junyeop Lee • Aim: Disease control
Last updated May 17, 2026 05:22 UTC
-
AI eye doctor: new study aims to spot Blindness-Causing diseases
Diagnosis Not yet recruitingThis study will develop an artificial intelligence (AI) system to detect major eye diseases like glaucoma, cataracts, and diabetic retinopathy. Researchers will use 15,000 existing eye images from Costa Rican patients to train and test the AI. The goal is to create a tool that wo…
Matched conditions: MACULAR DEGENERATION
Sponsor: Marisse Masis-Solano • Aim: Diagnosis
Last updated May 17, 2026 05:08 UTC
-
New study tests text remapping to boost reading for vision loss
Knowledge-focused Not yet recruitingThis study looks at whether moving words to different parts of the visual field can help people with central vision loss read faster and more accurately. About 100 adults with dense blind spots in the center of their vision will take part. Researchers will measure reading speed a…
Matched conditions: MACULAR DEGENERATION
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated May 17, 2026 05:04 UTC